Trials / Conditions / Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
4 registered clinical trials studyying Transthyretin Amyloidosis (ATTR) With Cardiomyopathy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy NCT06679946 | Alnylam Pharmaceuticals | Phase 3 |
| Recruiting | MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (AT NCT06128629 | Intellia Therapeutics | Phase 3 |
| Active Not Recruiting | HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy NCT04153149 | Alnylam Pharmaceuticals | Phase 3 |
| Active Not Recruiting | APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (AT NCT03997383 | Alnylam Pharmaceuticals | Phase 3 |